Colgate-Palmolive (NYSE:CL) PT Raised to $92.00 at Wells Fargo & Company

Colgate-Palmolive (NYSE:CLFree Report) had its target price increased by Wells Fargo & Company from $90.00 to $92.00 in a report published on Monday morning, Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.

A number of other research analysts also recently weighed in on the stock. UBS Group increased their target price on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a buy rating in a research report on Monday, January 29th. StockNews.com downgraded Colgate-Palmolive from a strong-buy rating to a buy rating in a research report on Tuesday, February 20th. TheStreet raised Colgate-Palmolive from a c+ rating to a b+ rating in a research report on Friday, January 26th. The Goldman Sachs Group assumed coverage on Colgate-Palmolive in a report on Friday, March 1st. They issued a buy rating and a $93.00 price objective for the company. Finally, Stifel Nicolaus upped their price objective on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the company a buy rating in a report on Monday. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of Moderate Buy and a consensus target price of $91.44.

Read Our Latest Stock Analysis on CL

Colgate-Palmolive Price Performance

CL stock opened at $91.90 on Monday. The company has a market capitalization of $75.40 billion, a P/E ratio of 29.08, a PEG ratio of 3.37 and a beta of 0.42. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.28 and a current ratio of 1.06. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $92.54. The company has a fifty day moving average price of $88.08 and a 200-day moving average price of $81.99.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.82 by $0.04. The company had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.73 EPS. As a group, equities analysts expect that Colgate-Palmolive will post 3.52 EPS for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date is Friday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Insiders Place Their Bets

In related news, insider Jennifer Daniels sold 5,790 shares of the firm’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $83.96, for a total value of $486,128.40. Following the completion of the sale, the insider now owns 63,236 shares in the company, valued at $5,309,294.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Jennifer Daniels sold 5,790 shares of Colgate-Palmolive stock in a transaction on Friday, February 16th. The stock was sold at an average price of $83.96, for a total transaction of $486,128.40. Following the completion of the transaction, the insider now directly owns 63,236 shares of the company’s stock, valued at $5,309,294.56. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. Over the last quarter, insiders sold 159,048 shares of company stock worth $13,336,846. 0.37% of the stock is owned by corporate insiders.

Institutional Trading of Colgate-Palmolive

Institutional investors and hedge funds have recently modified their holdings of the business. Union Savings Bank increased its position in Colgate-Palmolive by 76.6% during the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after purchasing an additional 134 shares in the last quarter. PSI Advisors LLC boosted its position in Colgate-Palmolive by 4,971.4% during the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock worth $32,000 after acquiring an additional 348 shares during the last quarter. OFI Invest Asset Management purchased a new stake in Colgate-Palmolive in the 3rd quarter worth approximately $25,000. Avion Wealth raised its holdings in Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after acquiring an additional 175 shares during the last quarter. Finally, Atlantic Edge Private Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter worth $32,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.